Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy
Ultrasound-guided Rhomboid Intercostal Block Versus Retrolaminar Block for Postoperative Analgesia After Thoracoscopic Sympathectomy: A Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Background: Although thoracoscopic sympathectomy is made via small incisions, it is associated with severe postoperative pain. Both Rhomboid intercostal block (RIB) and Retrolaminar block (RLB) are recent techniques used for pain control after such procedures Objectives: To compare the effectiveness of RIB and RLB in providing postoperative analgesia after thoracoscopic sympathectomy in adult patients and their impact on the patient's outcomes. Patients and Methods: This prospective, randomized (1:1), double-blind clinical trial; will be carried out on 60 patients scheduled for elective thoracoscopic sympathectomy under general anesthesia at our hospital. Patients will be randomly allocated into two equal groups (30 patients each) and will receive: in group A; general anesthesia with intraoperative ipsilateral ultrasound-guided RIB, whereas in group B; general anesthesia with intraoperative ipsilateral ultrasound-guided RLB.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2026
CompletedAugust 21, 2025
July 1, 2025
5 months
October 21, 2024
August 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean and Standard deviation of time to the first request of postoperative rescue analgesic (minutes) (mean±SD)
The time interval between the block performance and the first request of postoperative analgesia
24 hours after the end of surgery
Secondary Outcomes (2)
Mean and Standard deviation of Numeric Pain Rating Scale (NPRS) score (mean±SD)
24 hours after the end of surgery
Mean and Standard deviation of the total dose of the rescue analgesic consumed (milligrams) (mean±SD)
24 hours after the end of surgery
Study Arms (2)
Group A (n=30)
ACTIVE COMPARATORRhomboid Intercostal Block
Group B (n=30)
ACTIVE COMPARATORRetrolaminar Block
Interventions
Intraoperative Ipsilateral Ultrasound-guided RIB
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status ≤ II
- Age from 18 to 60 years
- Body Mass Index (BMI) \< 35 kg/m²
You may not qualify if:
- American Society of Anesthesiologists (ASA) physical status \> II
- Age \< 18 years or \> 60 years
- Body Mass Index (BMI) ≥ 35
- Local infection at the puncture site
- Altered mental status
- Pregnant women
- Allergy to study drugs
- Chronic pain
- Coagulation abnormalities or on anticoagulants
- Severe hepatic or kidney disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Damanhour Teaching Hospital
Damanhūr, El-Beheira, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed M Shaat, MD
Damanhour Teaching Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2024
First Posted
October 22, 2024
Study Start
August 1, 2025
Primary Completion
January 1, 2026
Study Completion
January 30, 2026
Last Updated
August 21, 2025
Record last verified: 2025-07